Devices that measure the clotting mechanisms of hemostasis used primarily to detect clotting deficiencies related to thromboembolic disease, thrombocytopenia, impaired liver function, hemophilia, von Willebrand disease, and other conditions. They are also used to monitor the effect of drugs such as heparin, oral anticoagulants, and thrombolytic and antiplatelet agents in whole blood, as well as the effects of blood component therapy.
Blood coagulation testing and analyzers market are expected to grow at a lucrative CAGR owing to factors such as developing healthcare infrastructure, rising healthcare spending coupled with increasing incidences of lifestyle-related conditions such as obesity, diabetes, and cardiovascular disorders. Special emphasis on providing quality and timely care to patients is expected to propel the growth of the diagnostic market, which in turn is anticipated to cause a hike in demand for hemostasis analyzers. Rapid expansion in hospitals and primary healthcare centers is expected to be a high impact rendering driver. Also, favorable government initiatives to improve the healthcare delivery are expected to help future growth of this market. Furthermore, availability of advanced equipment, which has higher accuracy and features to perform multiple tests, is another vital driver for the growth of blood coagulation and testing analyzers market.
The instruments segment is estimated to continue its dominance in the market during the forecast period and is expected to account for around 59% of the total market share by 2020. The segment’s growth can be directly related to the increase in the number of laboratories worldwide. Technological advances such as dual and four channel systems, which are capable of simultaneously carrying out APTT, PT, FIB, and TT are expected to boost the growth of this segment over the next four years.
The global Blood coagulation analyzer market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Blood coagulation analyzer volume and value at global level, regional level and company level. From a global perspective, this report represents overall Blood coagulation analyzer market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Blood coagulation analyzer in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Blood coagulation analyzer manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Roche Diagnostics
Sysmex
Gene-Tech Biomedicals
A&T
Sekisuichemical
Bexcoexports
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Automated Systems
Semi-Automated Systems
Manual Systems
Segment by Application
Hospitals
Clinical Laboratories
Point-of-Care Testing
Others
Summary:
Get latest Market Research Reports on Blood coagulation analyzer. Industry analysis & Market Report on Blood coagulation analyzer is a syndicated market report, published as Global Blood coagulation analyzer Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Blood coagulation analyzer market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.